Clinical Trial Update: Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY) [Phase 2]

View source ↗

Summary

Phase 2 CINERGY trial evaluating whether administering a calcineurin inhibitor to neurologically deceased donors can reduce delayed graft function in kidney tra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• Kidney Transplantation
• Organ Transplant Rejection

Drugs mentioned

• Calcineurin inhibitor (CINERGY trial)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Organ Transplant Failure or Rejection, Brain Death | Phase 2 | Status: ACTIVE_NOT_RECRUITING